In the PROGRESS-AMS trial, Erbel and colleagues assessed the feasibility of bioabsorbable coronary stents made from a magnesium alloy—demonstrated in animal pilot studies to be completely ...

"BD treats first subject in trial of bioabsorbable scaffold" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been ...

FRANKLIN LAKES, N.J., March 20, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...